Potential regulatory role of the farnesoid X receptor in the metabolic syndrome
- 23 December 2004
- Vol. 87 (1) , 93-98
- https://doi.org/10.1016/j.biochi.2004.11.018
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- The farnesoid X receptor: a novel drug target?Expert Opinion on Investigational Drugs, 2004
- Glucose Regulates the Expression of the Farnesoid X Receptor in LiverDiabetes, 2004
- Expression and activation of the farnesoid X receptor in the vasculatureProceedings of the National Academy of Sciences, 2004
- Natural Structural Variants of the Nuclear Receptor Farnesoid X Receptor Affect Transcriptional ActivationJournal of Biological Chemistry, 2003
- Global and societal implications of the diabetes epidemicNature, 2001
- Association of diabetes, serum insulin, and c-peptide with gallbladder diseaseHepatology, 2000
- The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjectsGut, 1999
- Gallstones and diabetes: A case-control study in a free-living population sampleHepatology, 1997
- Altered bile acid profiles in duodenal bile and urine in diabetic subjectsEuropean Journal of Clinical Investigation, 1988
- Cholesterol biosynthesis in nonketotic diabetics before and during insulin therapyDiabetes Research and Clinical Practice, 1987